Preview

Did Eli Lilly Pursue the Right Strategy to Enter the Indian Market?

Satisfactory Essays
Open Document
Open Document
287 Words
Grammar
Grammar
Plagiarism
Plagiarism
Writing
Writing
Score
Score
Did Eli Lilly Pursue the Right Strategy to Enter the Indian Market?
In 1993 Eli Lilly, one of the leading pharmaceutical firms in the USA, started a joint venture in India with the leading
Indian company Ranbaxy. The decision was dictated by the conditions of the US market and opportunities of the Indian market. Costlier manufacturing practices due to strict governmental control, soaring prices in 1990s, invasion of cheap generics to the USA market as opposed to low costs in India and new regulations that opened Indian market to foreign investments (up to 51%) created tempting conditions to enter one of the emerging huge markets of the world.
Alliance with Ranbaxy was a smart strategy for Eli Lilly to establish its presence in India. Ranbaxy was the second largest manufacturing company of bulk drugs and generics with domestic market share of 15% in India with established distribution network and the second largest exporter to different countries, including Russia (which Eli Lilly was attempting to reach), with capital cost 50-75% lower than those of comparable US plant and R&D expenses of 2-5% of sales. Besides,
Ranbaxy developed its own process for Eli Lilly's patented drug Cefaclor. Since Eli Lilly's product patent for Cefaclor expired in 1992 and the firm was expecting to protect its monopoly with process patents which were due to expire only in
1994, this gave great scope for a mutually advantageous agreement between the two companies. There was also possibility to conduct cheap clinical trials in India.
Although the joint venture ran into problems because of weak patent laws in the country, which prevented the American partner from sharing its research expertise, Eli Lilly obviously, realized the benefits of an arrangement with Ranbaxy in sourcing low-cost basic research from

You May Also Find These Documents Helpful

  • Satisfactory Essays

    Sirtris

    • 574 Words
    • 3 Pages

    * • Partnership with Pharma. As is almost always the case in biotech, the team was in…

    • 574 Words
    • 3 Pages
    Satisfactory Essays
  • Good Essays

    The purpose of this article is to figure out the most efficient way for Loblaw to open up new business in pharmaceutical industry. We believe that acquisition is the best.…

    • 821 Words
    • 4 Pages
    Good Essays
  • Powerful Essays

    Ego Executive Report

    • 3226 Words
    • 13 Pages

    Greene, W. (2007), “The emergence of India’s pharmaceutical industry and implications for the US Generic Drug Market”, US International Trade Commission.…

    • 3226 Words
    • 13 Pages
    Powerful Essays
  • Powerful Essays

    William, G. (2007). The Emergence of India’s Pharmaceutical Industry and Implications for the US Generic…

    • 4700 Words
    • 19 Pages
    Powerful Essays
  • Satisfactory Essays

    - Profits from sales of drugs in other regions were to be retained by Lilly, after a royalty was paid to the joint venture…

    • 771 Words
    • 4 Pages
    Satisfactory Essays
  • Better Essays

    El- Lilly: A pharmaceutical company was founded by a 38 year-old pharmacist and El lilly in May 1876, it was founded in Indianapolis, USA. By opening the door to a small laboratory. Currently it has its headquarter in Indianapolis Indiana, USA, with 38,000 employees worldwide. El-lilly focuses on meeting some of the world’s most urgent medical needs, in the areas of oncology, cardiovascular disease, diabetes, critical care, neuroscience, men’s health and musculoskeletal. El-Lilly has competitive advantage indulging world class scientist in its research and development to produce highest quality of medicine that would solve the world medical need on the areas of it focuses. Profitability by net income is $(mill) 4,088.6…

    • 1716 Words
    • 7 Pages
    Better Essays
  • Powerful Essays

    Threat of new entrants is relatively high. Companies forming alliances are potential rivals. Even if earlier such company was not considered to be a threat, after merging with some research and development company or forming alliance with another pharmaceutical company it would become a rival to Eli Lilly. The threat is however weakened by significant research and development costs necessary to successfully enter the business. Eli Lilly’s focus on a relatively narrow market of sedatives and antidepressants weakens the threat of new entrants, but other products that form lesser part of company’s sales such as insulin and others are exposed to high threat of new entrants. The need of obtaining certificates and licenses also weakens the threat of new entrants. Discussed above leads to the conclusion that threat of new entrants is medium.…

    • 1398 Words
    • 6 Pages
    Powerful Essays
  • Satisfactory Essays

    To carry out its mission, building a partnership with a major pharmaceutical company would be a reasonable strategy, which is also a prerequisite for its acquisition or IPO, an exit strategy for its investors from a financial perspective.…

    • 290 Words
    • 2 Pages
    Satisfactory Essays
  • Powerful Essays

    Following on his experience of medicines used in the Civil War, Colonel Eli Lilly, a Union Officer and a pharmacist, started a small pharmaceutical company in Indianapolis, Indiana, USA with the aim of producing high quality prescription drugs. After Colonel Lilly's death, his son Josiah K. Lilly Sr., and eventually his two grandsons, Eli Lilly and Josiah K. Lilly Jr., each served as president of the company. It was his grandson who led the company into the industrialized era by stressing upon the need of biomedical research and installing modern equipments to make the research successful. His interest in research paid off and since its inception the company has grown to be one of the largest and most influential pharmaceutical companies in the world, offering key pharmaceutical products in almost every key therapeutic area. It is a leading global manufacturer and distributor of pharmaceutical therapies in cancer, cardiovascular disease, central nervous system and endocrine system disorders, and infectious disease. Among the companies many breakthroughs are cephalosporin, erythromycin, insulin and Prozac which proved to be world's most widely prescribed antidepressant and was a major source of company's revenue for more than ten years. In addition to Prozac some of Lilly's famous product trademark includes Darvocet, Evista, Gemzar, Humalog, Humatrope and Zyprexa. Eli Lilly was the first distributor of methadone which is used frequently in the treatment of some of the narcotic drug addictions. In 2003 Eli Lilly introduced Cialis in partnership with biotechnology company ICOS to compete with Pfizer's blockbuster Viagra for erectile dysfunction. Lilly in collaboration with other organizations is providing low-cost antibiotics, training for international medical personnel and technology to enable the manufacture of products for treatment in China, India, and South Africa. In 2004 company registered…

    • 1724 Words
    • 7 Pages
    Powerful Essays
  • Powerful Essays

    The principle products are neurosciences type, which its largest selling product currently is Zyprexa for the treatment of schizophrenia, “bipolar mania and bipolar maintenance.” Recently in 2004 it released Cymbalta, a major depressive disorder treatment drug projecting sales to carry the company’s growth in stead of Zyprexa. Other lesser branches of research also include oncology products such as Gemzar, and Cardiovascular agents including ReoPro.…

    • 959 Words
    • 4 Pages
    Powerful Essays
  • Good Essays

    * Pfizer: Pharmaceutical companies have low pressures for local responsiveness as their products serve universalistic needs. Cost pressures on the other hand are intense therefore the most appropriate strategy is a Global one.…

    • 670 Words
    • 3 Pages
    Good Essays
  • Satisfactory Essays

    Eli Lily Case Study

    • 489 Words
    • 2 Pages

    It was a right strategy for Eli Lilly that started a joint venture with Ranbaxy to enter the Indian market. First of all, Ranbaxy was the second largest pharmaceutical company that manufactures bulk drugs and generic drugs in India, with a domestic market share of 15 per cent. It had established broad distribution network, and it was the second largest exporter of all products in India. Ranbaxy’s capital costs were 50 per cent to 75 per cent lower than those of comparable U.S. plants. Second, the timing was perfect for Eli Lilly to enter the Indian market. During 1970s, the Patents Act 1970 and the Drug Price Control Order (DPCO) was issued. And India was opening its drug market. Third, there was possibility to conduct cheap clinical trials in India.…

    • 489 Words
    • 2 Pages
    Satisfactory Essays
  • Powerful Essays

    The Story of Eli Lilly

    • 3384 Words
    • 14 Pages

    Kevin Schwartz, Director, PrTM (kschwartz@prtm.com), and Bret huff, VP of Chemical Products r&D, Eli Lilly and Company, (huff_bret_e@lilly.com)…

    • 3384 Words
    • 14 Pages
    Powerful Essays
  • Powerful Essays

    Lilly is planning on reorganizing its approach to selling drugs in the US. It will decrease the number of sales reps it employs and shift its focus towards building deeper relationships with individual physicians. It is expected that this reorganization will help Eli Lilly's sales…

    • 1158 Words
    • 5 Pages
    Powerful Essays
  • Good Essays

    P&G and Godrej

    • 278 Words
    • 2 Pages

    Godrej gave the following explanations for the breakup of the joint venture. It would enable both the companies to pursue the business opportunities thrown open by liberalization. Strangely, the reasoning given for the alliance when it had been formed about four years ago was that it would enable them to exploit better the opportunities provided by…

    • 278 Words
    • 2 Pages
    Good Essays

Related Topics